pigs were used in a feed preference study consisting of 2 feed preference comparisons. Pigs did not differentiate diets containing either 1,378 or 13,780 IU vitamin D 3 /kg but consumed less (P < 0.01) of a diet containing 44,100 IU vitamin D 3 /kg compared with the diet containing 1,378 IU vitamin D 3 /kg. Overall, these studies demonstrate that supplementing vitamin D 3 above basal concentrations used in these studies is effective at increasing circulating 25(OH)D 3 , but the supplement did not influence growth or bone mineralization. Also, concentrations of vitamin D 3 of 44,100 IU/kg of the diet may negatively affect feed preference of nursery pigs.
INTRODUCTION
Vitamin D is a group of fat-soluble secosteriods. The 2 major dietary sources of vitamin D are vitamin D 2 (ergocalciferol) and vitamin D 3 (cholecalciferol). Pigs discriminate in their metabolism and more readily utilize vitamin D 3 (Horst et al., 1981) . Vitamin D 3 is produced in the photochemical conversion of 7-dehydrocholesterol within the skin of animals when exposed to sunlight or a synthetic UVb light source (De Luca, 1979 3 ] by the 24α-hydroxylase enzyme. The 1,25 dihydroxycholecalciferol [1, 25(OH) 2 D] metabolite is the physiologically active form that with parathyroid hormone and calcitonin maintains Ca and P homeostasis in the body (Dittmer and Thompson, 2010) .
Recently, the presence of the vitamin D receptor in many soft tissues not associated with normal Ca and P homeostasis (Norman and Bouillon, 2010) has been found. This has raised interest in its involvement in other normal bodily functions. Since serum 25(OH)D concentrations are the best biomarker of vitamin D exposure (IOM, 2011) human health researchers have used serum 25(OH) D concentrations of 5 ng/mL or less to be a diagnostic tool for vitamin D deficiency. In the swine industry, commercially reared pigs at weaning exhibited lower than expected serum 25(OH)D concentrations (Madson, 2011) , which suggest additional supplementation may be beneficial. Therefore, our objectives were to determine if supplementation of vitamin D 3 above amounts typically supplied in diets by the U.S. swine industry affects 25(OH) D 3 concentrations, growth, bone mineralization, and feed preference of preweaned and nursery pigs.
MATERIALS AND METHODS
All experimental procedures and animal care were approved by the Kansas State Institutional Animal Care and Use Committee. Diets were formulated to meet or exceed all nutrient requirement estimates (NRC, 2012) .
Experiments were conducted in totally enclosed, environmentally controlled, mechanically ventilated facilities. Experiments 1 and 4 were conducted at the Kansas State University Swine Teaching and Research Center (Manhattan, KS). The preweaning portion of Exp. 2 was performed at a commercial farrowing facility (Innovative Swine Solutions, Carthage, IL), and the nursery portion was conducted at the Kansas State University Segregated Early Weaning Facility (Manhattan, KS). Experiment 3 was conducted in a commercial nursery facility (New Fashion Pork Inc., Buffalo Center, IA).
Experiment 1
A total of 270 pigs from 29 litters (327 × 1050; PIC, Hendersonville, TN; initially 1 to 2 d of age) were used in a 52-d study to determine the effects of oral vitamin D 3 supplementation on growth, serum 25(OH)D 3 concentrations, and bone mineralization of pre-and postweaning pigs.
Shortly after farrowing, pigs were allotted to 1 of 3 oral dosage vitamin D 3 treatments. Glycomyr Inc. (Ames, IA) prepared the oral vitamin D 3 dosage treatments by solubilizing varying concentrations of vitamin D 3 in ethanol and this solution was mixed with peanut oil. The solution also contained antioxidant ingredients (tertiary butylhydroquinone and citric acid) and an antifoaming ingredient (dimethylpolysiloxane). Confirmation of vitamin D 3 concentrations were performed using an HPLC technique (Hofsass et al., 1976) . Dosage treatments were 1) a control 1 mL oral dosage with no supplemental vitamin D 3 , 2) 1 mL of treatment 1 but containing 40,000 IU vitamin D 3 , or 3) 1 mL of treatment 1 but containing 80,000 IU vitamin D 3 . Pigs were allotted to treatments on 2 different days (d 0 or 2 of the trial) during the week of farrowing. This allowed pigs to be placed on test at either 1 or 2 d after farrowing. Pigs were allotted to treatments in a randomized complete block design and matched sets within litter were considered blocks. To perform the allotment, pigs were weighed on their respective allotment days and 3 pigs closest in weight within a litter were considered a matched set. The number of matched sets per litter was variable depending on number of pigs born and weight variation; however, gender was balanced across treatments. Each pig was ear tagged for identification, and pigs within each matched set were randomly allotted and dosed with 1 of the 3 oral treatments. No cross-fostering was performed on treatment pigs; however, extra pigs were cross-fostered to balance the number of suckling pigs across litters. Pigs were weighed again on d 10, 18, and 20 to determine preweaning growth. During the lactation period, neither creep feed nor other supplements were provided except the respective oral vitamin D 3 dosage. Management of all pigs, including processing methods, was similar throughout the trial and consistent with standard farm procedures. Sow gestation and lactation diets were corn-soybean meal based with 40% dried distillers grains with solubles (DDGS) in gestation and 20% DDGS in lactation and contained added vitamin D 3 at 1,378 IU/kg of complete diet. The diets were formulated to 0.55 and 0.94% standardized ileal digestible Lys in gestation and lactation diets, respectively. The farrowing barn contained 29 farrowing crates (2.13 by 0.61 m for the sow and 2.13 by 0.91 m for the pigs) that were each equipped with a single feeder and nipple waterer. Necropsies were performed on pigs that died during the lactation period to verify that there were no lesions associated with vitamin D toxicity (metastatic calcification of soft tissues). In total, 18 pigs (5-7 per treatment excluding pigs euthanized for tissue collection) died throughout the preweaning portion of the study.
On d 20, the remaining 234 pigs (pigs that survived to weaning) were weaned into the nursery facility and penned by treatment. The nursery barn had 34 pens (1.22 by 1.52 m) with wire mesh flooring; each pen contained a 4-hole, dry self-feeder and a nipple waterer to provide ad libitum access to feed and water. Sets of pens were blocked to minimize the effect of location. Pigs were assigned to a set of pens, maintaining the integrity of the initial matched sets within a pen set. There were 6 to 7 pigs per pen and a total of 11 or 12 replications per treatment (due to preweaning death, replications were uneven during the nursery portion of the study). Nursery diets were fed in a common 3-phase dietary program (Table 1) . The phase 1 diets (A and B diets) were fed from d 20 to 25 in a pelleted form. The phase 2 and 3 diets were fed from d 25 to 39 and d 39 to 52, respectively, in meal form. All pigs and feeders were weighed on d 20, 25, 32, 39, 46, and 52 to determine ADG, ADFI, and G:F.
Within each litter, 1 matched set that was closest to the mean pig weight at time of allotment was bled via jugular venipuncture to determine initial serum 25(OH) D 3 concentrations. The same pigs were bled again on d 10, 20 (weaning), 30, and 52 to determine serum 25(OH)D 3 concentrations.
Tissue and Bone Sampling
On d 18, 6 matched sets (6 pigs/treatment and 1 matched set/litter) were selected for necropsy, which was conducted on d 19. Matched sets selected for necropsy 11 Natuphos 600; BASF, Florham Park, NJ. Provided 780, 1,021, and 1,021 phytase units/kg of the complete diet for phase 1, 2, and 3 diets, respectively. Phase 1 diets used in Exp. 1 diet not contain phytase.
12 Kem-Gest: phosphoric, fumaric, lactic, and citric acid. Kemin Industries Inc., Des Moines, IA.
13 Phytase provided 0.12, 0.13, and 0.12% available P for phase 1, 2, and 3, diets, respectively. Phase 1 diets used in Exp. 1 did not contain phytase.
were chosen to balance for gender and litter among experimental treatments. Mean BW of pigs selected for necropsy were consistent with the mean BW of treatment populations. Necropsies were conducted at the Kansas State University College of Veterinary Medicine. All necropsies performed were in compliance with the college's standard operating procedures. All pigs selected for necropsy were euthanized with an intravenous overdose of sodium pentobarbital (Fatal Plus; Vortech Pharmaceuticals, Dearborn, MI). On d 19, both femurs and second ribs were collected to determine bone ash content, and the fourth ribs and tibias were sampled for histopathology examination. Mesenteric lymph nodes were collected from control pigs and pigs that received 80,000 IU vitamin D 3 . Mesenteric lymph nodes were isolated, rinsed in cold saline, and homogenized in approximately 10 volumes of TRIzol reagent (Invitrogen, Carlsbad, CA). Samples were then kept frozen at -86°C before analysis for abundance of tumor necrosis factor (TNFα) mRNA. On d 35, 12 pigs (6 from the control treatment and 6 from the 80,000 IU vitamin D 3 treatment) balanced for BW, litter, and gender were selected for necropsy, and bones were sampled with the same procedures performed on d 19.
Collection and Preparation of Bones for Histological Examination
Muscles and connective tissues were cleaned from bone surfaces, and bones were split longitudinally with a hacksaw. Blood was washed from the cut surfaces, and gross evaluations were performed. Bones were then placed in 10% neutral buffered formalin and allowed to fix at room temperature for 24 h, after which they were decalcified in commercial decalcification solution (CalEx Decalcifier; Fisher Scientific, Fair Lawn, NJ) according to the manufacturer's directions. The bones were then washed for 30 min in running water, and the proximal portion of each tibia, including the proximal growth plate, and both ribs, including the costochondral junction and 2 to 3 cm of adjacent bone, were routinely embedded in paraffin wax, sectioned at 4 µm, mounted on glass slides, and stained with hematoxylin and eosin. All bone samples were collected and examined by a board-certified pathologist who was blinded to vitamin D 3 treatments.
Bone Ash Analysis
After collection, femurs and ribs were stored at -20°C until they were thawed and placed in petroleum ether for fat extraction. Bones were soaked in the ether for 7 d at room temperature (25°C) and then removed from the ether and dried at 100°C until a consistent dry weight was achieved. Upon completion of drying, all bones were ashed at 600°C for 24 h. Final ash contents were collected and expressed as a percentage of dry fatfree bone.
Ribonucleic Acid Sample Analysis
Each homogenate of lymphoidal tissue was thawed at room temperature; 500 μL was placed in a clean microfuge tube and then the sample was mixed thoroughly with 100 μL chloroform for 15 sec and centrifuged at 12,000 × g for 15 min at 4°C. The upper aqueous phase was removed (250 μL) and mixed with 0.93 volumes of 75% ethanol. The mixture was then applied to an RNeasy spin column (Qiagen Inc., Germantown, MD) and processed as described by the manufacturer with the exception that an additional wash with 2 M NaCl and 2 mM EDTA (pH 4.0) was included. Ribonucleic acid was eluted in 50 μL of water, and the concentration was obtained by UV spectrometry. One microgram of RNA was then used as a template for production of cDNA in a 20-μL reaction volume using random hexamers and Superscript III (Invitrogen, Carlsbad, CA) as described by the manufacturer. Afterward, samples were diluted to 100 μL final volume with Tris-EDTA buffer and stored at -20°C before PCR analysis.
Quantitative real-time PCR was performed using a Stratagene Mx3005p cycler (Stratagene, La Jolla, CA) and PerfeCTa SYBR Green Fast mix reagent (Quanta Biosciences, Gaithersburg, MD). Amplification of porcine target cDNAs was accomplished with the following primers (synthesized by Integrated DNA Technologies, Coralville, IA): pGAPDH-For, 5′-TGTCCCCACCCCCAACGTGT; pGAPDH-Rev, 5′-GAGGGCAATGCCAGCCCCAG; pTNFα-For, 5′-GCAGGAGCCACCACGCTCTT; and pTNFα-Rev, 5′-CGTGGGCGACGGGCTTATCT. Aliquots (8.3 ng) of cDNA were amplified under the following conditions: 95°C for 30 s followed by 45 cycles of 95°C for 1 s and 57°C for 30 s. All reactions were performed in duplicate with 6 pigs/treatment, and relative mRNA abundance was quantified by the delta cycles to threshold (C t ) method with glyceraldehyde-3-phosphate dehydrogenase (GAPDH) to normalize values as previously described by Giulietti et al. (2001) and Das et al. (2009) .
Experiment 2
A 38-d study was conducted using a total of 398 barrows (1050; PIC, Hendersonville, TN; initially 7 d of age) in a commercial farrowing facility in a 2 × 2 split plot design to determine the effects of supplementing vitamin D 3 from either a single oral dose or from dietary concentrations up to 60 times the requirement (220 IU) for nursery pigs (NRC, 2012) on pig growth and serum 25(OH)D 3 . The hypothesis was that vitamin D 3 supplementation would increase preweaning growth of pigs suckled in a commercial production facility.
On d 7 after birth, weight-matched pairs of barrows within litters were allotted to 1 of 2 oral dosage treatments (none or 40,000 IU vitamin D 3 ) in a randomized complete block design. Barrows were weighed on d 7 and at weaning (d 21) to determine preweaning growth. Matched pair barrows were not cross-fostered; however, extra pigs were cross-fostered to balance the number of suckling pigs across litters. The study used barrows from 80 litters in 3 farrowing rooms that contained 39 stalls (2.13 by 0.61 m for the sow and 2.13 by 0.91 m for the pigs), 1 self-feeder, and a nipple waterer.
At weaning (d 21), pigs were transported approximately 7 h (623 km) to the nursery facility, which contained 80 pens (1.52 by 1.52 m) with metal slatted floors. Each pen contained one 5-hole dry self-feeder and a nipple waterer to allow for ad libitum access to feed and water. A subset of 300 barrows were used from d 21 to 45 to determine the effects of the previously administered vitamin D 3 dose and 2 concentrations of dietary vitamin D 3 (1,378 or 13,780 IU vitamin D 3 /kg of complete diet) in early nursery diets (d 21 to 31) on pig performance and serum 25(OH)D 3 . Barrows were subsampled to reduce the number of lightweight, nonviable pigs in the nursery portion of the study and to maintain the integrity of matched pairs originally established on d 7 after birth. Barrows were allotted to pens based on their previously administered vitamin D 3 dose, and pens were randomly assigned to dietary treatments. There were 5 pigs per pen and 15 pens per treatment. The only difference between the diets fed from d 21 to 31 was vitamin D 3 level (Table 1 ). The diets contained 0.80% Ca and 0.63% available P. A common diet (1,378 IU/kg, 0.70% Ca, and 0.47% available P) was fed from d 31 to 45. Pigs and feeders were weighed on d 21, 26, 31, 38, and 45 to determine ADG, ADFI, and G:F.
Serum was collected from 12 pigs per treatment at weaning (d 21), d 31, and d 45 to determine serum 25(OH) D 3 . Pigs selected for serum sampling were from 12 randomly selected pens per treatment; selected pigs were closest to the average pen weight at allotment to dietary treatments.
Barrows were vaccinated for porcine circovirus type 2 (PCV2) and Mycoplasma hyopnuemoniae (M. hyo) on d 29. A 1-dose product (Ingelvac CircoFLEX, CircoFLEX; Boehringer Ingelheim Vetmedica, Inc., St. Joseph, MO) was given for PCV2. A 2-dose product was used for the M. hyo vaccine (Respisure; Pfizer Animal Health, New York, NY). Serum samples collected at weaning (d 21) and d 64 were analyzed for PCV2 antibody titers to distinguish potential effects of supplemental vitamin D 3 on acquired immunity.
Porcine Circovirus Type 2 Antibody Titer Analysis
Serum was analyzed for antibodies against PCV2 using an indirect fluorescent assay (IFA) at the Kansas State University Veterinary Diagnostic Laboratory. Titration endpoints were calculated as the reciprocal of the last serum dilution that gave a positive fluorescence result. Before analysis, all IFA titers were log 2 transformed to approximate a normal distribution of titers. Log 2 transformed antibody titers were used to quantify the change in antibody titer from weaning (d 21) to d 64 based on supplemental vitamin D 3 treatments.
Experiment 3
A total of 864 pigs (PIC TR4 × FAST ADN; initially 21 d of age) were used in a 30-d nursery study to determine the effects of vitamin D 3 supplementation via the water supply on nursery growth performance and serum 25(OH)D 3 concentrations.
Upon arrival to the facility, pigs were placed in pens and pens were randomly assigned to 1 of 2 water solubilized vitamin D 3 treatments (none [control] corn-soybean meal-based diets containing 10% whey and 4.5% fish meal (Table 1 ). The first preference comparison was between diets containing 1,378 (control) or 13,780 IU vitamin D 3 /kg of the complete diet, and the second comparison was between diets containing 1,378 (control) and 44,100 IU vitamin D 3 /kg of the complete diet. The levels were selected to represent feeding concentrations approximately 6x, 60x, and 200x the requirement (NRC, 2012). All pens (1.22 by 1.52 m) contained two 3-hole dry selffeeders and a nipple waterer to allow for ad libitum access to feed and water. Diets were placed in separate feeders, and feeders were positioned adjacent to each other. Every morning, feeders were weighed and relocated in the pen to discourage location bias. Total pen feed intake was calculated, and intake of each diet for both comparisons was expressed as a percentage of total intake.
Serum 25-Hydroxycholecalciferol, Calcium, and Phosphorus Analysis
All blood samples were collected via jugular venipuncture using 25-mm × 20-gauge needles and 10-mL blood collection tubes containing a gel separator to determine circulating 25(OH)D 3 serum concentrations. Six hours after collection, blood was centrifuged (1,600 × g for 25 min at 2°C) and serum was harvested and stored at -20°C until analysis. Serum 25(OH)D 3 concentrations were determined by Heartland Assays (Ames, IA) using a previously described RIA (Hollis et al., 1993) . Assays conducted by this laboratory have a lower detectable limit for 25(OH)D 3 of 2.5 ng/mL. Individual samples that were below the detectable limit (n = 3) were assigned concentrations of 2.5 ng/mL. Calcium and P analyses for Exp. 1 were conducted at the Iowa State University College of Veterinary Medicine (Ames, IA) by using spectrophotometry with commercial kits (Pointe Scientific Inc., Canton, MI) and methods described by Pointe Scientific (2009a,b) .
Dietary Vitamin D 3 Analysis
Feed samples were collected from Exp. 2 and 4 to validate vitamin D 3 concentrations. Samples were collected at the conclusion of the experimental diet feeding period, pooled by treatment, and subsampled for analysis. Premixes containing vitamin D 3 from Exp. 2 and 4 were also sampled for analysis. All diet and premix samples were analyzed by DSM Nutritional Products Inc. (Parsippany, NJ) for vitamin D 3 analysis using a combination of HPLC and mass spectrometry (Schadt et al., 2012) .
Statistical Analysis
All data were analyzed using the PROC MIXED procedure of SAS (SAS Inst. Inc., Cary, NC), and treatment means were analyzed using the LSMEANS statement. All serum 25(OH)D 3 analyses and PCV2 antibody titer analyses from Exp. 2 were conducted using the RE-PEATED function of SAS to determine treatment main effects over time and treatment × time interactions. Data from Exp. 1 were analyzed as a randomized complete block design with litter and matched set within litter as the blocking factors. Individual pig was the experimental unit for preweaning growth performance, serum 25(OH)D 3 , bone ash determination, and TNFα mRNA relative abundance. Pen was the experimental unit for nursery growth performance. Preplanned CONTRAST statements were used to determine linear and quadratic contrasts based on oral vitamin D 3 treatment. For Exp. 2, data were analyzed as a randomized complete block design with the main effects of oral dosage and diet treatment and dosage × diet interactions. Individual pig was the experimental unit for preweaning growth performance, serum 25(OH)D 3 , and PCV2 antibody titers. For preweaning growth performance, initial weight was used as a covariate and sow was a random effect in the statistical model. Pen was the experimental unit for nursery growth performance. Data from Exp. 3 were analyzed as a randomized complete block design with barn location as a blocking factor and water vitamin D 3 level as the main effect. Pen was the experimental unit and initial BW on d 0 was used as a covariate. Serum 25(OH)D 3 was analyzed using individual pig as the experimental unit. Finally, data for Exp. 4 were analyzed as a completely randomized design, and differences associated with the main effect of diet on the percentage of total feed intake were determined in both comparisons. All results were considered significant at P ≤ 0.05 and considered trends at P ≤ 0.10.
RESULTS

Experiment 1
Before weaning (d 0 to 20), no significant differences were observed for ADG (Table 2) (Fig. 2) serum Ca concentrations on the initial day of collection, d 10, or d 30. However, differences for serum Ca were observed on d 20 (linear, P = 0.05) and d 52 (quadratic, P = 0.02), with serum Ca increasing with increasing supplementation of vitamin D 3 . Serum P concentrations were not influenced (Fig. 3) by supplementation of vitamin D 3 in an oral dose. Correlation analysis showed that serum 25(OH) D 3 was a poor indicator of serum Ca (r 2 ≤ 0.03) or serum P (r 2 ≤ 0.05) on any sampling day.
Bone ash from femurs of pigs euthanized on d 19 showed no effect of vitamin D 3 dosage (Table 3) , but second-rib ash content tended (linear, P = 0.09) to decrease as oral vitamin D 3 dosage increased. No differences were found in bone ash content of femurs or second ribs collected on d 35.
No macroscopically visible differences were observed in the growth plates of either the tibias or the ribs. Histologically, all ribs from both collection days (d 19 and 35) were similar in their progression of chondrocytes through the normal maturation zones. The zones had a normal, even, and abrupt transition to primary spongiosa, which undergoes remodeling to form secondary spongiosa and trabecular bone. The growth plates were uniform in width across their length. The growth plates of all tibias were uniform and were undergoing the normal progression from cartilage to bone formation and mineralization. Finally, mesenteric lymph node abundance of TNFα mRNA was (P < 0.01; Fig. 4 ) lower for pigs dosed with 80,000 IU of vitamin D 3 than for control pigs.
Experiment 2
Analysis of vitamin D 3 concentrations in the diets verified that they were within acceptable analytical error of formulated dietary values. Analysis of experimental diets showed that vitamin D 3 mean concentrations were 1,267 and 10,347 IU/kg for diets formulated to contain added vitamin D 3 at 1,378 and 13,780 IU/kg of the complete diet, respectively. Vitamin D 3 oral dose did not influence preweaning growth (Table 4) 
Experiment 3
Supplementation of vitamin D 3 in the water supply did not affect (Table 5) 
Experiment 4
Analysis of vitamin D 3 concentrations in the diets verified that they were within the acceptable analytical error of formulated dietary values. Analysis of experimental diets showed that vitamin D 3 mean concentrations were 1,711, 15,554, and 49,604 IU/kg for diets formulated to contain added vitamin D 3 at 1,378, 13,780, and 44,100 IU/kg of the complete diet, respectively. No preference differences, expressed as a percentage of total feed intake, were observed between diets formulated to contain 1,378 or 13,780 IU of vitamin D 3 /kg (49 vs. 51% of 0.54 kg ADFI) throughout the length of the study (Fig. 5) . Conversely, when pigs were offered a choice between diets formulated to contain either 1,378 IU or 44,100 IU vitamin D 3 /kg (67 vs. 33% of 0.52 kg ADFI), pigs consumed a greater portion (P = 0.03) of the diet containing 1,378 IU of vitamin D 3 /kg.
DISCUSSION
Vitamin D 3 requirements set by the NRC (2012) for the nursery pig are 220 IU/kg of the complete diet for pigs ranging from 5 to 11 kg and 200 IU/kg of the complete diet for pigs from 11 to 25 kg. On the other hand, vitamin D 3 levels in commercial diets often contain 5 to 7 times these concentrations (Reese and Hill, 2010) . Previous research has extensively evaluated the supplementation of . Superscripts denote differences (P < 0.05) due to a, linear oral dosage effect, and b, a quadratic oral dosage effect, or tendencies (0.05 < P ≤ 0.10) due to x, linear oral dosage effect, and y, quadratic oral dosage effect. Physiological range: based on Friendship et al. (1984) . dietary vitamin D 3 at concentrations similar to the dietary requirement of nursery pigs (100 to 250 IU/kg of the diet), but no research has looked at supplementing vitamin D 3 in alternative forms as discussed in the current studies or at levels above those typically supplemented in commercial diets. Comparing results in the present experiments to those previously discussed is challenging due to the difference in concentration of vitamin D 3 supplementation.
In the present experiments, preweaning and nursery growth performance were not influenced by supplementing vitamin D 3 above the normal industry inclusion rates. Although numerical differences were observed in weaning weights of pigs dosed with vitamin D 3 , no statistical differences were found; therefore, it appears additional supplementation may not be a significant factor in preweaning growth. Rortvedt and Crenshaw (2012) found that growth performance was decreased in nursery pigs that were fed diets with no supplemental vitamin D and marginal Ca and P concentrations after sows were fed maternal diets without supplemental vitamin D 3 . The authors did not report any observed decreases in preweaning performance, which may suggest that vitamin D is not a significant factor in Ca and P homeostasis in the neonatal pig; however, when the authors fed marginal Ca and P levels in the nursery diets (80% of NRC [1998] requirement) of the same pigs, they observed decreased performance. When Ca and P were supplemented above the animal's requirement (120% of NRC [1998] requirement), they were able to retain normal growth performance. Wahlstrom and Stolte (1958) supplemented pigs with 90 IU of vitamin D 2 /kg of the diet with adequate dietary Ca and P and observed no improvement in growth performance. Combs et al. (1966) also observed that supplementation of vitamin D 2 at 220 or 880 IU/kg of the diet did not influence growth performance. Johnson and Palmer (1939) and Bethke et al. (1946) observed increased growth performance of pigs supplemented with vitamin D 2 . Both of these studies, however, were preceded with vitamin D depletion periods before the vitamin supplementation, and Ca and P concentrations were marginal in the diets, which caused clinical symptoms of rickets and Ca tetany that were 7 Dose × diet × day interaction, P = 0.99; day main effect, P < 0.01.
8 PCV2 = porcine circovirus type 2. Serum collected on d 21 (weaning) and 5 wk postvaccination was sent to the K-State Veterinary Diagnostic Laboratory for indirect fluorescent antibody assay (IFA).
9 Endpoint antibody titers determined by IFA were log 2 transformed. avoided due to the vitamin D supplementation treatments. Ultimately, conclusions from previous research have suggested that dietary supplementation of vitamin D above the animal's requirement will not affect growth performance unless the animal is deficient in the vitamin or in Ca and P. The present studies suggest that supplementation of vitamin D 3 at levels above commercially formulated dietary concentrations does not affect growth performance regardless of the form of supplementation. Bone ash data collected from second ribs and femurs of pigs in Exp. 1 showed no change in bone mineralization of pigs dosed with vitamin D 3 compared with control pigs. Overall, bone ash percentages determined in Exp. 1 as a percentage of dry fat-free bone were lower than typical reference values (58 to 62%; Salas, 2011) . Our finding of the lower-than-normal bone ash percentages determined in this study may be a function of pig age when euthanized (19 d and 35 d of age). Previous work conducted by Crenshaw et al. (1981) found increased bone ash content with increased age from pigs at 2, 4, 6, and 8 mo of age. Additionally, the bones collected in Exp. 1 were placed in petroleum ether as whole bones and were not split, which may have not allowed for complete fat extraction of internal organic matter associated with the medullary cavity. As a result, the bone ash percentages were intermediate compared with those typically referenced for wet bone and dry fat-free bone. A statistical tendency was observed for bone ash percentage to decrease in second ribs of pigs dosed with increasing vitamin D 3 . This may coincide with increased 1,25(OH) 2 D 3 activity increasing osteoclastic mobilization of Ca to resupply blood calcium concentrations; however, this process is tightly regulated, and because 1,25(OH) 2 D 3 activity within bones or mature osteoclast cell numbers was not determined, this is not a definitive conclusion. More research quantifying the impact of vitamin D 3 supplementation on 1,25(OH) 2 D 3 concentrations and interactions with bone Ca mobilization may help clarify this relationship. Similar to growth performance, bone ash as an indicator of bone mineralization has proven to be affected only when dietary Ca and P are limiting or when vitamin D has been deficient in the animal (Rortvedt and Crenshaw, 2012) .
Bone histology conducted on the tibias and fourth ribs collected from pigs euthanized in Exp. 1 were considered consistent with normal bone development because microscopic evaluation showed a normal progression of chondrocytes through their maturation zones and abrupt transitions from cartilage tissue to mineralized bone tissue. Dittmer and Thompson (2010) reviewed the role of vitamin D and rickets in domestic animals and described distinct histological differences in animals with clinical signs of rickets. These differences include cartilage plugs extending in the metaphysis and thickening of the physis. Overall, the bone histological examinations conducted in Exp. 1 concluded that no significant differences were observed due to the supplementation of vitamin D 3 in an oral dose.
The role of vitamin D in immunity is a topic of growing interest, especially in human health research. For innate immunity, human research conducted by Liu et al. (2006) 3 Hi-D 2X (Alpharma LLC, Eagle Grove, IA) was included in water source to achieve the desired experimental vitamin D 3 supplementation concentrations.
4 Experimental water treatments were administered from d 0 to 10; from d 10 to 30, pigs were provided a control water source with no supplemental vitamin D 3 .
5 There were 24 pigs per pen and 18 replications per treatment. 6 A total of 12 pigs/treatment were bled via jugular venipuncture to determine serum 25(OH)D 3 concentrations.
7 Day × treatment interaction, P < 0.01; day main effect, P < 0.01. a potent antimicrobial peptide, within the macrophage. In a review on acquired immunity, Bikle (2009) discussed evidence that vitamin D inhibited maturation of dendritic cells and promoted the TH2 type immune responses with a shift from TH1 type responses. These qualities may be beneficial for those suffering from autoimmune diseases such as inflammatory arthritis, inflammatory bowel disease, and experimental allergic encephalitis (EAE; a model for multiple sclerosis) but may be detrimental to immune defense against specific infectious agents.
In Exp. 1, a reduction in TNFα mRNA abundance was observed in lymphatic tissue of pigs dosed with 80,000 IU of vitamin D 3 compared with control pigs. These results agree with the work of Cantorna et al. (1998) , who suggested that vitamin D 3 promotes anti-inflammatory cytokine gene expression, but more research is needed to verify this initial finding and whether these differences would have any biological significance. In Exp. 2, acquired immunity was assessed by measurements of PCV2 antibody titers after vaccination with a single 1 mL dose. No differences were detected among vitamin D 3 supplemented groups. A majority of the research conducted in an attempt to quantify the role of vitamin D in immunity has been conducted in mice. The initial data from the current studies suggest similar results may be true for swine; however, the work done in the current studies was performed in an attempt to quantify the cytokine mRNA abundance and PCV2 antibody titer. More research using controlled disease and infectious challenge models need to be conducted to draw truly valid conclusions.
For vitamin D, the most widely used biomarker of exposure in humans is circulating 25(OH)D concentrations (IOM, 2011) . This is because circulating 25(OH)D has the longest serum half-life of 10 d to 3 wk. However, serum 25(OH)D has yet to be clearly established as a biomarker of effect, this is due to the tight metabolic regulation of 1,25(OH) 2 D (calcitriol), the active form of vitamin D that elicits effects within the body.
In the current experiments, half-life of circulating 25(OH)D 3 concentrations appeared to be approximately 10 d for pigs dosed with supplemental vitamin D 3 , which agrees with previous research conducted in humans. The determination of "adequate" circulating concentrations of 25(OH)D in humans has been debated due to a lack of information available on the level needed for optimal calcium metabolism and peak bone mass. Health has been introduced into this discussion due to observational studies that describe the relationship of low serum 25(OH)D concentrations in individuals who have tuberculosis (Nnoaham and Clarke, 2008) , but no work has defined whether vitamin D plays a distinct role in reducing the risk of the disease. Similar debates have occurred in swine research due to increased incidence of metabolic bone disease in production systems.
The normal range of circulating 25(OH)D concentrations defined in human nutrition is the mean serum 25(OH) D concentration ± 2 SD from a group of healthy individuals in human recommendations (IOM, 1997). Specker et al. (1992) concluded that circulating 25(OH)D concentrations below 11 ng/mL are consistent with vitamin D deficiency in human infants and neonates. Additionally, Salas (2011) described normal serum 25(OH)D 3 concentrations in neonatal swine to range from 5 to 15 ng/mL. Circulating 25(OH)D concentrations appear to be similar for swine and humans, but an adequate level may be more closely defined in human research due to studies that have observed elevations in alkaline phosphatase and parathyroid hormone (PTH) concentrations to be associated with low serum 25(OH)D (Demay, 1995) ; to our knowledge, this type of comparison has not been performed in swine. In the current experiments, serum 25(OH)D 3 concentrations of control pigs were slightly lower than the range previously described for neonatal pigs (3.6 ± 1.15 ng/mL for Exp. 1). Based on the definition of normal range to be the mean ± 2 SD, the value would fall into the previously described range for young swine, but the previously mentioned reference values did not describe the recommended range of 25(OH)D 3 for nursery pigs. Because no pigs in the current set of studies exhibited clinical symptoms associated with metabolic bone disease or rickets, our results suggest that circulating 25(OH)D 3 concentrations in pigs were adequate to maintain calcium homeostasis and ideal bone development. Serum Ca and P concentrations determined in Exp. 1 were within previously described normal ranges (Friendship et al., 1984) of weanling pigs. Based on this information, even though vitamin D 3 supplementation level significantly influenced serum Ca on d 20 and 52, all serum Ca and P values obtained throughout the study were at elevated concentrations well above reference values associated with deficiency. Correlations of circulating 25(OH)D 3 concentrations to serum Ca and P suggest that no correlations exist when vitamin D 3 is supplemented at levels above typically formulated concentrations.
Interestingly, in Exp. 4, the inclusion of vitamin D 3 at 44,100 IU/kg of the diet reduced the intake preference of the particular diet. Previous recommendations by NRC (1987) established maximum vitamin D 3 concentrations for pigs at 33,000 IU/kg of diet if they were fed for less than 60 d and at 2,200 IU/kg if fed for more than 60 d. The concentration fed in Exp. 4 was 44,100 IU/kg of the complete diet, thus possibly explaining the reduced percentage of overall feed intake for that diet. A study conducted by Quarterman et al. (1964) concluded that daily supplementation of 250,000 IU vitamin D 3 for 4 wk reduced feed intake and growth rate, and calcification was observed in several soft tissues after necropsy. This phenomenon of soft organ calcification was previously described by Holmes and Kummerow (1983) as a result of increased Ca retention in the body.
In conclusion, the supplementation of vitamin D 3 at levels above those typically used in commercial diets did not influence growth performance, bone mineralization, serum Ca and P, or bone histology. Supplementation of vitamin D 3 increased the circulating concentration of 25(OH)D 3 . Additionally, at concentrations greater than 200 times the requirement (200 IU/kg; NRC, 2012) vitamin D 3 affects feed preference. Therefore, future research is needed to determine optimal serum 25(OH)D 3 levels for proper bone development and ideal Ca and P absorption in pigs. Research to examine the potential effects of vitamin D on the immune system or other novel biological processes in pigs may offer additional insights into the potential benefits of vitamin D supplements for pigs.
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